Ameriprise Financial Inc Gilead Sciences, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,891,804 shares of GILD stock, worth $174 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,891,804

Previous 1,993,255 5.09%

Holding current value

$174 Million

Previous $137 Million 15.95%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $6.76 Million - $8.52 Million	-101,451 Reduced 5.09%	1,891,804 $159 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $23.2 Million - $26.8 Million	367,878 Added 22.63%	1,993,255 $137 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $2.59 Million - $3.16 Million	36,246 Added 2.28%	1,625,377 $119 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $8.4 Million - $9.53 Million	-114,652 Reduced 6.73%	1,589,131 $129 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $8.52 Million - $9.29 Million	115,189 Added 7.25%	1,703,783 $128 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $6.85 Million - $7.82 Million	-90,181 Reduced 5.37%	1,588,594 $122 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $15.8 Million - $18 Million	204,240 Added 13.85%	1,678,775 $139 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $8.56 Million - $12.3 Million	-137,378 Reduced 8.52%	1,474,535 $127 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $3.12 Million - $3.57 Million	-52,441 Reduced 3.15%	1,611,913 $100 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $9.99 Million - $11.2 Million	-172,999 Reduced 9.42%	1,664,354 $102 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $23.1 Million - $28.9 Million	398,731 Added 27.72%	1,837,353 $105 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $15.5 Million - $17.6 Million	238,965 Added 19.92%	1,438,622 $102 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $175 Million - $189 Million	-2,587,398 Reduced 68.32%	1,199,657 $83.8 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $9.99 Million - $10.9 Million	-157,445 Reduced 3.99%	3,787,055 $261 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $38 Million - $43.3 Million	-632,551 Reduced 13.82%	3,944,500 $255 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $3.36 Million - $3.83 Million	-59,296 Reduced 1.28%	4,577,051 $268 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $8.81 Million - $11.1 Million	141,898 Added 3.16%	4,636,347 $291 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $125 Million - $145 Million	-1,727,247 Reduced 27.76%	4,494,449 $346 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $59.1 Million - $75.6 Million	-942,965 Reduced 13.16%	6,221,696 $468 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $11.9 Million - $13.1 Million	-193,192 Reduced 2.63%	7,164,661 $466 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $45.5 Million - $50.2 Million	-728,023 Reduced 9.0%	7,357,853 $466 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $31.2 Million - $34.9 Million	503,477 Added 6.64%	8,085,876 $547 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $232,236 - $260,165	3,714 Added 0.05%	7,582,399 $493 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $83.7 Million - $109 Million	1,381,794 Added 22.3%	7,578,685 $474 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $6.23 Million - $6.89 Million	-87,350 Reduced 1.39%	6,196,891 $487 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $64.6 Million - $75.4 Million	996,408 Added 18.84%	6,284,241 $445 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $11 Million - $13.4 Million	151,184 Added 2.94%	5,287,833 $399 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $26.3 Million - $30.8 Million	-369,059 Reduced 6.7%	5,136,649 $368 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $397 Million - $471 Million	5,505,708	5,505,708 $446 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Gilead Sciences, Inc. Transaction History